Columns

Nasdaq Tender for NYSE Could Come Within a Week

The situation could change, of course, if the NYSE reverses course and formally considers the joint bid from Nasdaq and the IntercontinentalExchange, as some shareholders want.

FT's Martin Wolf Gets it Wrong Again

Financial Times columnist Martin Wolf joins a media coterie that resurrects one of the hoariest myths of all about infant mortality rates in the U.S., this time to attack GOP Rep. Paul Ryan’s budget cutbacks to Medicaid.

Grasso Welcomed Back to NYSE With Open Arms

Exclusive: NYSE CEO Duncan Niederauer has extended an invitation to Grasso to attend the Big Board’s commemoration of the 10-year anniversary of the Sept. 11 terrorist attacks.

No, We Are Not a Nation of Hamburger Flippers

Emac: Is hamburger flipping becoming the predominant trait of America's labor force like last month's payroll data suggest, or will the nation turn back to its manufacturing roots? 

DOJ, SEC Asked to Probe Whether Goldman Lied, Defrauded Clients

Two U.S. Senators have formally asked the Justice Department and the Securities and Exchange Commission to investigate whether Goldman Sachs’ executives defrauded clients and whether its executives including CEO Lloyd Blankfein committed perjury before Congress.

Blankfein to Battle Angry Shareholders

Emac: Perjury charges, government probes, Catholic nuns, fat cat pay. Goldman Sachs faces its most contentious annual meeting in its history as Wall Street’s most powerful firm.

Ted Forstmann Being Treated for Brain Cancer

Ted Forstmann has been in many corporate battles over the past four decades as one of Wall Street’s premier deal makers, but now he finds himself in what may be the biggest battle of his life.

Top Senate Democrat Questions Aid to Pakistan

A top Democrat member of the powerful Senate Appropriations committee said lawmakers should reconsider U.S. foreign aid to Pakistan until questions have been answered about whether Pakistan knowingly harbored 9/11 terrorist Osama bin Laden.